Dermbits - Watch short videos of KOLs answering your questions

AI-powered search

hero

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions

What distinguishes the MOA of ritlecitinib from other JAK inhibitors?

Alopecia

What distinguishes the MOA of ritlecitinib from other JAK inhibitors?

Featuring Charlie Dunn, MD

Does patient age impact the effectiveness and safety of ritlecitinib?

Alopecia

Does patient age impact the effectiveness and safety of ritlecitinib?

Featuring Charlie Dunn, MD

How should patients be educated about the potential long-term outcomes of ritlecitinib therapy?

Alopecia

How should patients be educated about the potential long-term outcomes of ritlecitinib therapy?

Featuring Charlie Dunn, MD

How soon can patients with alopecia areata begin to see results on ritlecitinib?

Alopecia

How soon can patients with alopecia areata begin to see results on ritlecitinib?

Featuring Charlie Dunn, MD

How does ritlecitinib perform in patients with severe alopecia areata?

Alopecia

How does ritlecitinib perform in patients with severe alopecia areata?

Featuring Charlie Dunn, MD

What lab assessments are recommended prior to initiating ritlecitinib?

Alopecia

What lab assessments are recommended prior to initiating ritlecitinib?

Featuring Charlie Dunn, MD

What are the most common adverse reactions seen with ritlecitinib?

Alopecia

What are the most common adverse reactions seen with ritlecitinib?

Featuring Charlie Dunn, MD

What are some early signs and symptoms associated with alopecia areata?

Alopecia

What are some early signs and symptoms associated with alopecia areata?

Featuring Charlie Dunn, MD

Can dietary changes, lifestyle modifications, or supplements influence the course of alopecia areata?

Alopecia

Can dietary changes, lifestyle modifications, or supplements influence the course of alopecia areata?

Featuring Charlie Dunn, MD

How does the presence of comorbidities influence the management of alopecia areata?

Alopecia

How does the presence of comorbidities influence the management of alopecia areata?

Featuring Charlie Dunn, MD

Psoriasis

How does the safety profile of ixekizumab compare to other IL-17 inhibitors?

Featuring Saakshi Khattri , MD

How soon can patients on ixekizumab for psoriasis expect to see results?

Psoriasis

How soon can patients on ixekizumab for psoriasis expect to see results?

Featuring Saakshi Khattri , MD

Can ixekizumab be safely used in patients with comorbidities like hepatitis B or tuberculosis?

Psoriasis

Can ixekizumab be safely used in patients with comorbidities like hepatitis B or tuberculosis?

Featuring Saakshi Khattri , MD

Who is the ideal patient for ixekizumab, and are there any notable exclusions?

Psoriasis

Who is the ideal patient for ixekizumab, and are there any notable exclusions?

Featuring Saakshi Khattri , MD

What patient education points are important to convey to patients starting ixekizumab?

Psoriasis

What patient education points are important to convey to patients starting ixekizumab?

Featuring Saakshi Khattri , MD

Are there any dose adjustments needed for patients with renal or hepatic impairment when using ixekizumab?

Psoriasis

Are there any dose adjustments needed for patients with renal or hepatic impairment when using ixekizumab?

Featuring Saakshi Khattri , MD

Are there any head-to-head studies comparing ixekizumab to other biologics?

Psoriasis

Are there any head-to-head studies comparing ixekizumab to other biologics?

Featuring Saakshi Khattri , MD

Do patients with nail and scalp psoriasis have a greater risk of developing psoriatic arthritis?

Psoriasis

Do patients with nail and scalp psoriasis have a greater risk of developing psoriatic arthritis?

Featuring Saakshi Khattri , MD

What are the most important factors to consider when selecting a first-line biologic for patients with psoriasis?

Psoriasis

What are the most important factors to consider when selecting a first-line biologic for patients with psoriasis?

Featuring Saakshi Khattri , MD

How do you manage patients with psoriasis with concurrent inflammatory bowel disease?

Psoriasis

How do you manage patients with psoriasis with concurrent inflammatory bowel disease?

Featuring Saakshi Khattri , MD

What are the most common adverse reactions seen with ixekizumab?

Psoriasis

What are the most common adverse reactions seen with ixekizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for ixekizumab?

Psoriasis

What is the dosing regimen for ixekizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What factors should be considered when determining optimal treatment duration for ixekizumab in patients with psoriasis?

Psoriasis

What factors should be considered when determining optimal treatment duration for ixekizumab in patients with psoriasis?

Featuring Raj Chovatiya, MD, PhD, MSCI

Is ixekizumab safe for use in pediatric populations?

Psoriasis

Is ixekizumab safe for use in pediatric populations?

Featuring Raj Chovatiya, MD, PhD, MSCI

24 of 586